S. 4120Senate117th Congress (2021-2023)Enacted

Childhood Cancer STAR Reauthorization Act

Sponsored by Jack ReedSen. Jack Reed (D-RI)
Introduced April 28, 2022

AI-Generated Summary

Updated February 8, 2026 at 11:00 AM UTC

The Childhood Cancer STAR Reauthorization Act renews and expands the 2018 Childhood Cancer STAR program for another five‑year period (2024‑2028). It aims to speed up discovery and access to promising childhood cancer treatments by improving biorepository use, strengthening survivorship research, and supporting health‑care workforce development. The changes affect children and adolescents with cancer, researchers using biospecimens, the National Institutes of Health, and the Department of Health and Human Services.

Key Provisions

  • Extends the reauthorization of the Childhood Cancer STAR Act to cover fiscal years 2024 through 2028.
  • Requires the NIH Director, within two years, to review and report on procedures for researcher access to children’s cancer biorepository samples, seeking to reduce administrative burden while protecting privacy.
  • Amends biorepository language to explicitly include solid tumor samples and updates references to the reauthorized act.
  • Shifts survivorship program focus from pilot programs to research evaluation, mandates awards for research on childhood and adolescent cancer survivorship, and adds tools for secure electronic transfer of treatment information between providers.
  • Adds a requirement for the Department of Health and Human Services to develop recommendations for workforce development in psychosocial care for pediatric cancer patients and survivors.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

16 earlier actions
Became Law Latest Action

Became Public Law No: 117-350.

January 5, 2023

View full timeline
SenateIntro Referral

Introduced in Senate

April 28, 2022

SenateIntro Referral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2221)

April 28, 2022

SenateCommittee

Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

December 20, 2022

SenateFloor

Measure laid before Senate by unanimous consent. (consideration: CR S9613-9614)

December 20, 2022

SenateFloor

Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S9613-9614)

December 20, 2022

SenateFloor

Message on Senate action sent to the House.

December 21, 2022

HouseFloor

Received in the House.

December 21, 2022 • 12:09 PM

HouseFloor

Held at the desk.

December 21, 2022 • 12:16 PM

HouseFloor

Mr. Pallone moved to suspend the rules and pass the bill.

December 22, 2022 • 11:54 AM

HouseFloor

Considered under suspension of the rules. (consideration: CR H10025-10026)

December 22, 2022 • 11:55 AM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on S. 4120.

December 22, 2022 • 11:55 AM

SenateFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H10025-10026)

December 22, 2022 • 11:59 AM

HouseFloor

On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H10025-10026)

December 22, 2022 • 11:59 AM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

December 22, 2022 • 11:59 AM

President

Presented to President.

December 28, 2022

Became Law

Signed by President.

January 5, 2023

Became Law

Became Public Law No: 117-350.

January 5, 2023

Floor Debate

2 members

What members said about S. 4120 on the floor

2 Democrats
Jack Reed
Sen. Jack ReedD-RI · Apr 28, 2022

Mr. President, I am pleased to be joined by Senators Capito, Van Hollen, and Murkowski in introducing the Childhood Cancer Survivorship, Treatment, Access, and Research, STAR, Reauthorization Act of…

Jack Reed
Sen. Jack ReedD-RI · Apr 28, 2022

Mr. President, I am pleased to be joined by Senators Capito, Van Hollen, and Murkowski in introducing the Childhood Cancer Survivorship, Treatment, Access, and Research, STAR, Reauthorization Act of…

Mazie K. Hirono
Sen. Mazie K. HironoD-HI · Apr 28, 2022

Mr. President, I rise today to introduce the Sexual Harassment Independent Investigations and Prosecution Act, also known as the SHIIP Act, which addresses longstanding systemic problems in the way…

Bill Text

4 versions available

Reading Mode
Latest
Enrolled BillPublication date not provided

One Hundred Seventeenth Congress of the United States of America

2d Session

Begun and held at the City of Washington on Monday, the third day of January, two thousand and twenty two

S. 4120

AN ACT

To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes.

1.

Short title

This Act may be cited as the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act.

2.

Reauthorizing and improving the Childhood STAR Act

(a)

Children's cancer biorepositories

Section 417E of the Public Health Service Act (42 U.S.C. 285a–11) is amended—

(1)

in subsection (a)—

(A)

in paragraph (2)(A), by inserting before the period at the end of the second sentence the following: , such as collected samples of both solid tumor cancer and paired samples;

(B)

in paragraph (9), by striking Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 and inserting Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022;

(C)

by redesignating paragraph (10) as paragraph (11); and

(D)

by inserting after paragraph (9) the following:

(10)

Report on researcher access to children's cancer biorepository samples

Not later than 2 years after the date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022, the Director of NIH shall—

(A)

conduct a review of the procedures established under paragraph (2)(C) and other policies or procedures related to researcher access to such biospecimens to identify any opportunities to reduce administrative burden, consistent with paragraph (2)(D), in a manner that protects personal privacy to the extent required by applicable Federal and State privacy law, at a minimum; and

(B)

submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the findings of the review under subparagraph (A) and whether the Director of NIH plans to make any changes to the policies or procedures considered in such review, based on such findings.

; and

(2)

in subsection (d), by striking 2019 through 2023 and inserting 2024 through 2028.

(b)

Cancer survivorship programs

Section 201 of the Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 (Public Law 115–180) is amended—

(1)

in subsection (a)—

(A)

in the subsection heading, by striking Pilot programs to explore and inserting Research to evaluate

(B)

in paragraph (1)—

(i)

by striking may make awards to eligible entities to establish pilot programs and inserting shall, as appropriate, make awards to eligible entities to conduct or support research;

(ii)

by striking model systems and inserting approaches;

(iii)

by inserting and adolescent after childhood; and

(iv)

by striking evaluation of models for;

(C)

in paragraph (2)—

(i)

in subparagraph (A), in the matter preceding clause (i), by inserting within the existing peer review process, after practicable,; and

(ii)

in subparagraph (B)(v), by striking in treating survivors of childhood cancers and inserting in carrying out the activities described in paragraph (1); and

(D)

in paragraph (3)(B)(v), by striking design of systems for the effective transfer of treatment information and care summaries from cancer care providers to other health care providers and inserting design tools to support the secure electronic transfer of treatment information and care summaries between health care providers or, as applicable and appropriate, longitudinal childhood cancer survivorship cohorts; and

(2)

in subsection (b)—

(A)

in each of paragraphs (1) and (2), by striking date of enactment of this Act and inserting date of enactment of the Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022; and

(B)

in paragraph (1)—

(i)

by striking subparagraphs (A) and (C);

(ii)

by redesignating subparagraph (B) as subparagraph (A); and

(iii)

by adding at the end the following:

(B)

recommendations for enhancing or promoting activities of the Department of Health and Human Services related to workforce development for health care providers who provide psychosocial care to pediatric cancer patients and survivors.

.

Speaker of the House of Representatives

Vice President of the United States and President of the Senate